Faster global financial news!
Replimune wins FDA approval for its skin cancer drug, but shares tumble
svmuu.com07/08/2026 12:55
Complaint Report
Complaint Report
Replimune has received FDA approval for its skin cancer drug, marking a successful third attempt to gain clearance. Despite the approval, the company's shares are tumbling.
Source：Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
APEX Coin Value Analysis: Distinguishing Investment Potential Between APEX Network and ApeX Protocol
-
2
Exploring ICX and RSC: Analyzing Multiple Innovative Forces in the Blockchain World
-
3
Fed’s FIMA Repo Facility Went Unused for 8th Straight Week, suggesting Japan didn’t use the tool in its latest effort to support the yen
-
4
AVN Coin Trading Guide: Avian Project Overview and Current Trading Channel Analysis
-
5
MetaMask Aggregation Trading Feature Feedback: Convenience vs. Fee Trade-off
-
6
EY-Parthenon expects the Fed to keep interest rates unchanged through year-end, citing a stable labor market despite Wall Street's payroll expectations.
-
7
OpenAI is accelerating the development of its first consumer-grade smart speaker, with plans for a 2027 release and a price point of $300-400. Apple has filed a lawsuit alleging trade secret infringement.
-
8
EMIT Token Issuance Price and Time Machine NFTs Project Analysis: Market Status of Two Projects with the Same Name
-
9
Coinbase's Kite service is experiencing delayed sends/receives.
-
10
Mainstream USDT Trading Platforms and Receiving Wallets Inventory
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
